Literature DB >> 2108792

Heterogeneity of pseudohypoparathyroidism type I from the aspect of urinary excretion of calcium and serum levels of parathyroid hormone.

K Mizunashi1, Y Furukawa, H E Sohn, R Miura, S Yumita, K Yoshinaga.   

Abstract

Urinary excretion of calcium (Ca) was measured in 9 patients with pseudohypoparathyroidism (PHP) type I--3 with Albright's hereditary osteodystrophy (AHO): AHO(+) and 6 without AHO: AHO(-)--and in 13 with idiopathic hypoparathyroidism (IHP), treated with active vitamin D3 (1,25(OH)2D3 or 1 alpha OHD3) to maintain serum Ca levels at 8.4-9.5 mg/dl. Fasting urinary excretion of Ca in PHP was significantly lower than that in IHP. Moreover, fasting urinary excretion of Ca in PHP AHO(+) was lower than that in PHP AHO(-). This difference was also seen in the urine after oral loading of Ca. Urinary excretion of sodium (Na) was not different between PHP AHO(+) and PHP AHO(-). Serum levels of immunoreactive PTH in PHP AHO(+) were higher than those in PHP AHO(-). The difference in urinary excretion of Ca between PHP AHO(+) and PHP AHO(-) may come from the difference in the circulating levels of PTH.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2108792     DOI: 10.1007/bf02555000

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  24 in total

1.  THE RENAL CLEARANCE OF ENDOGENOUS "CREATININE" IN MAN.

Authors:  J Brod; J H Sirota
Journal:  J Clin Invest       Date:  1948-09       Impact factor: 14.808

2.  Evidence for a defect in the formation of 1alpha,25-dihydroxyvitamin D in pseudohypoparathyroidism.

Authors:  T K Sinha; H F DeLuca; N H Bell
Journal:  Metabolism       Date:  1977-07       Impact factor: 8.694

3.  Further studies on pseudo-hypoparathyroidism: report of four new cases.

Authors:  H ELRICK; F ALBRIGHT; F C BARTTER; A P FORBES; J D REEVES
Journal:  Acta Endocrinol (Copenh)       Date:  1950

4.  The effects of calcium and vitamin D metabolites on cytoplasmic mRNA coding for pre-proparathyroid hormone in isolated parathyroid cells.

Authors:  J Russell; J Silver; L M Sherwood
Journal:  Trans Assoc Am Physicians       Date:  1984

5.  Studies on the attainment of normocalcemia in patients with pseudohypoparathyroidism.

Authors:  N A Breslau; D D Notman; J M Canterbury; A M Moses
Journal:  Am J Med       Date:  1980-06       Impact factor: 4.965

6.  Stimulatory guanine nucleotide binding protein activity in the erythrocyte membrane of patients with pseudohypoparathyroidism type I and related disorders.

Authors:  T Saito; Y Akita; H Fujita; Y Furukawa; Y Tsuchiya; T Yasuda; M Yamamoto; T Kitagawa; Y Nakagawa; A Takehiro
Journal:  Acta Endocrinol (Copenh)       Date:  1986-04

7.  Effects of active vitamin D3 and parathyroid hormone on the serum osteocalcin in idiopathic hypoparathyroidism and pseudohypoparathyroidism.

Authors:  K Mizunashi; Y Furukawa; R Miura; S Yumita; H E Sohn; K Yoshinaga
Journal:  J Clin Invest       Date:  1988-09       Impact factor: 14.808

8.  Effect of parathyroid hormone on 1,25-dihydroxyvitamin D formation in type I pseudohypoparathyroidism.

Authors:  L Aksnes; D Aarskog
Journal:  J Clin Endocrinol Metab       Date:  1980-12       Impact factor: 5.958

9.  Regulation by vitamin D metabolites of messenger ribonucleic acid for preproparathyroid hormone in isolated bovine parathyroid cells.

Authors:  J Silver; J Russell; L M Sherwood
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

10.  Renal responses to PTH in patients with hormone-resistant (pseudo) hypoparathyroidism.

Authors:  A M Moses; N Breslau; R Coulson
Journal:  Am J Med       Date:  1976-08       Impact factor: 4.965

View more
  5 in total

1.  Development and treatment of tertiary hyperparathyroidism in patients with pseudohypoparathyroidism type 1B.

Authors:  Nicola M Neary; Diala El-Maouche; Rachel Hopkins; Steven K Libutti; Arnold M Moses; Lee S Weinstein
Journal:  J Clin Endocrinol Metab       Date:  2012-06-26       Impact factor: 5.958

2.  The effect of graded calcium infusions on rhythmic blood pressure oscillations in normal man.

Authors:  M Munakata; Y Imai; K Mizunashi; J Hashimoto; H Sekino; Y Furukawa; K Abe
Journal:  Clin Auton Res       Date:  1995-02       Impact factor: 4.435

3.  Erythrocytosis in pseudohypoparathyroidism type I.

Authors:  K Mizunashi; T Shishido; Y Furukawa; K Endo; K Ota; T Kimura; K Abe
Journal:  Clin Investig       Date:  1994-05

4.  The modulatory effect of endogenous parathyroid hormone on the action of hydrochlorothiazide in pseudohypoparathyroidism type I.

Authors:  K Mizunashi; Y Furukawa; K Abe; K Yoshinaga
Journal:  Calcif Tissue Int       Date:  1994-06       Impact factor: 4.333

5.  The effect of endogenous parathyroid hormone, exogenous calcitonin, and dibutyryl cyclic AMP on urinary excretion of N-acetyl-beta-D-glucosaminidase.

Authors:  K Mizunashi; Y Furukawa; K Yoshinaga
Journal:  Calcif Tissue Int       Date:  1994-03       Impact factor: 4.333

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.